Literature DB >> 8113319

Normoglycemia (not hypoglycemia) optimizes outcome from middle cerebral artery occlusion.

G M de Courten-Myers1, M Kleinholz, K R Wagner, R E Myers.   

Abstract

We examined the effects of serum glucose concentration during middle cerebral artery (MCA) occlusion in the cat on death rates in animals that died from hemispheric edema and on infarct size in animals that survived. We occluded that MCA permanently in some groups and released the clip after 8 h in others. By injecting or infusing glucose solutions, saline, or insulin, we maintained six animal groups steadily either hyper-, normo-, or slightly hypoglycemic before and for 6 or 8 h after permanent or 8-h temporary MCA occlusion. Studies with these groups revealed a distinct optimal outcome with normoglycemic animals. In three additional groups, we altered the glycemia after permanent occlusion from hyper- to normo- or hypoglycemia and from normo- to hyperglycemia. Two of the three hypoglycemic groups (8-h reversible and permanent hyper- to hypoglycemic occlusions) yielded the worst outcomes in this study, with > 10x larger median infarcts than the best outcome group (normoglycemic permanent occlusion). Hyperglycemia also was detrimental and increased infarct size and mortality after permanent occlusion. Restoring the cerebral blood flow after 8 h of occlusion increased the death rate from hemispheric edema compared with a maintained occlusion. Following permanent MCA occlusion, converting from normo- to hyperglycemia or vice versa yielded outcomes intermediate between a sustained normo- or hyperglycemia. A regression analysis of the normo- and hyperglycemic groups and the two groups with glycemia altered after permanent occlusion showed a significant linear correlation between glycemia level at and 1 h after MCA occlusion and median infarct size.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8113319     DOI: 10.1038/jcbfm.1994.29

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  15 in total

1.  The management of plasma glucose in acute cerebral ischaemia and traumatic brain injury: more research needed.

Authors:  Anthony J Strong
Journal:  Intensive Care Med       Date:  2008-03-05       Impact factor: 17.440

Review 2.  Hyperglycemia in aneurysmal subarachnoid hemorrhage: a potentially modifiable risk factor for poor outcome.

Authors:  Nyika D Kruyt; Geert Jan Biessels; J Hans DeVries; Merel J A Luitse; Marinus Vermeulen; Gabriel J E Rinkel; W Peter Vandertop; Yvo B Roos
Journal:  J Cereb Blood Flow Metab       Date:  2010-07-14       Impact factor: 6.200

3.  Potential link between post-acute ischemic stroke exposure to hypoglycemia and hemorrhagic transformation.

Authors:  Kyle D Klingbeil; Sebastian Koch; Kunjan R Dave
Journal:  Int J Stroke       Date:  2017-11-14       Impact factor: 5.266

4.  Effects of Diabetes Mellitus and Admission Glucose in Patients Receiving Mechanical Thrombectomy: A Systematic Review and Meta-analysis.

Authors:  Guang-Dong Lu; Zi-Qi Ren; Jin-Xing Zhang; Qing-Quan Zu; Hai-Bin Shi
Journal:  Neurocrit Care       Date:  2018-12       Impact factor: 3.210

Review 5.  Hyperglycemia, acute ischemic stroke, and thrombolytic therapy.

Authors:  Sherif Hafez; Maha Coucha; Askiel Bruno; Susan C Fagan; Adviye Ergul
Journal:  Transl Stroke Res       Date:  2014-03-13       Impact factor: 6.829

Review 6.  Diabetic aggravation of stroke and animal models.

Authors:  Ashish K Rehni; Allen Liu; Miguel A Perez-Pinzon; Kunjan R Dave
Journal:  Exp Neurol       Date:  2017-03-06       Impact factor: 5.330

Review 7.  Hyperglycaemia and infarct size in animal models of middle cerebral artery occlusion: systematic review and meta-analysis.

Authors:  Niall J J MacDougall; Keith W Muir
Journal:  J Cereb Blood Flow Metab       Date:  2010-12-15       Impact factor: 6.200

8.  Glucose modulation of spreading depression susceptibility.

Authors:  Ulrike Hoffmann; Inna Sukhotinsky; Katharina Eikermann-Haerter; Cenk Ayata
Journal:  J Cereb Blood Flow Metab       Date:  2012-09-12       Impact factor: 6.200

9.  Subjecting acute ischemic stroke patients to continuous tube feeding and an intensive computerized protocol establishes tight glycemic control.

Authors:  N D Kruyt; G J Biessels; T M Vriesendorp; J H Devries; J B L Hoekstra; P W Elbers; L J Kappelle; P Portegies; M Vermeulen; Y B W E M Roos
Journal:  Neurocrit Care       Date:  2009-05-27       Impact factor: 3.210

10.  The Stroke Hyperglycemia Insulin Network Effort (SHINE) trial protocol: a randomized, blinded, efficacy trial of standard vs. intensive hyperglycemia management in acute stroke.

Authors:  Askiel Bruno; Valerie L Durkalski; Christiana E Hall; Rattan Juneja; William G Barsan; Scott Janis; William J Meurer; Amy Fansler; Karen C Johnston
Journal:  Int J Stroke       Date:  2013-03-19       Impact factor: 5.266

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.